BNPs are strong predictors of HF presence and severity and provide prognostic information; therefore, BNP and NT-proBNP have a class 1 recommendation in the current European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) HF guidelines for these indications [3,4]. The gene discussed is NPPB; the disease is hydrops fetalis.